Table of Contents Author Guidelines Submit a Manuscript
International Journal of Otolaryngology
Volume 2013, Article ID 848021, 6 pages
http://dx.doi.org/10.1155/2013/848021
Clinical Study

Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes

1Department of Head and Neck Surgery, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, QC, Canada
2Department of Hematology and Medical Oncology, CHUM, Montreal, QC, Canada
3Department of Radiation Oncology, CHUM, Montreal, QC, Canada

Received 4 January 2013; Revised 22 March 2013; Accepted 27 March 2013

Academic Editor: David W. Eisele

Copyright © 2013 Eric Bissada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2008,” CA: A Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. C. Irish and A. Bernstein, “Oncogenes in head and neck cancer,” Laryngoscope, vol. 103, no. 1, part 1, pp. 42–52, 1993. View at Google Scholar · View at Scopus
  3. J. S. McDonald, H. Jones, Z. P. Pavelic, L. J. Pavelic, P. J. Stambrook, and J. L. Gluckman, “Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck,” Journal of Oral Pathology and Medicine, vol. 23, no. 8, pp. 342–346, 1994. View at Google Scholar · View at Scopus
  4. W. G. Yarbrough, C. Shores, D. L. Witsell, M. C. Weissler, M. E. Fidler, and T. M. Gilmer, “ras mutations and expression in head and neck squamous cell carcinomas,” Laryngoscope, vol. 104, no. 11, part 1, pp. 1337–1347, 1994. View at Google Scholar · View at Scopus
  5. J. A. Anderson, J. C. Irish, and B. Y. Ngan, “Prevalence of RAS oncogene mutation in head and neck carcinomas,” Journal of Otolaryngology, vol. 21, no. 5, pp. 321–326, 1992. View at Google Scholar · View at Scopus
  6. J. M. Spencer, S. M. Kahn, W. Jiang, V. A. DeLeo, and I. B. Weinstein, “Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas,” Archives of Dermatology, vol. 131, no. 7, pp. 796–800, 1995. View at Google Scholar · View at Scopus
  7. M. Barbacid, “ras genes,” Annual Review of Biochemistry, vol. 56, pp. 779–827, 1987. View at Google Scholar · View at Scopus
  8. S. A. Belinsky, T. R. Devereux, R. R. Maronpot, G. D. Stoner, and M. W. Anderson, “Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines,” Cancer Research, vol. 49, no. 19, pp. 5305–5311, 1989. View at Google Scholar · View at Scopus
  9. J. Bornholdt, J. Hansen, T. Steiniche et al., “K-ras mutations in sinonasal cancers in relation to wood dust exposure,” BMC Cancer, vol. 8, article 53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Huncharek, J. Muscat, and J. F. Geschwind, “K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases,” Carcinogenesis, vol. 20, no. 8, pp. 1507–1510, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. C. S. Karapetis, S. Khambata-Ford, D. J. Jonker et al., “K-ras mutations and benefit from cetuximab in advanced colorectal cancer,” The New England Journal of Medicine, vol. 359, no. 17, pp. 1757–1765, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. R. E. Howell, F. S. H. Wong, and R. G. Fenwick, “A transforming Kirsten ras oncogene in an oral squamous carcinoma,” Journal of Oral Pathology and Medicine, vol. 19, no. 7, pp. 301–305, 1990. View at Google Scholar · View at Scopus
  13. S. E. Chang, P. Bhatia, N. W. Johnson et al., “Ras mutations in United Kingdom examples of oral malignancies are infrequent,” International Journal of Cancer, vol. 48, no. 3, pp. 409–412, 1991. View at Google Scholar · View at Scopus
  14. D. Saranath, L. T. Bhoite, M. G. Deo et al., “Detection and cloning of potent transforming gene(s) from chewing tobacco- related human oral carcinomas,” European Journal of Cancer B, vol. 30, no. 4, pp. 268–277, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Rumsby, R. L. Carter, and B. A. Gusterson, “Low incidence of ras oncogene activation in human squamous cell carcinomas,” British Journal of Cancer, vol. 61, no. 3, pp. 365–368, 1990. View at Google Scholar · View at Scopus
  16. W. A. Yeudall, L. K. Torrance, K. A. Elsegood, P. Speight, C. Scully, and S. S. Prime, “ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions,” European Journal of Cancer B, vol. 29, no. 1, pp. 63–67, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. R. L. M. Ruíz-Godoy, C. M. García-Cuellar, N. E. Herrera González et al., “Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma,” Journal of Experimental and Clinical Cancer Research, vol. 25, no. 1, pp. 73–78, 2006. View at Google Scholar · View at Scopus
  18. E. Rizos, G. Sourvinos, D. A. Arvanitis, G. Velegrakis, and D. A. Spandidos, “Low incidence of H-, K- and N-ras oncogene mutations in cytological specimens of laryngeal tumours,” Oral Oncology, vol. 35, no. 6, pp. 561–563, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Hirano, P. E. Steele, and J. L. Gluckman, “Low incidence of point mutation at codon 12 of K-ras proto-oncogene in squamous cell carcinoma of the upper aerodigestive tract,” Annals of Otology, Rhinology and Laryngology, vol. 100, no. 7, pp. 597–599, 1991. View at Google Scholar · View at Scopus
  20. H. Kiaris, D. A. Spandidos, A. S. Jones, E. D. Vaughan, and J. K. Field, “Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck,” British Journal of Cancer, vol. 72, no. 1, pp. 123–128, 1995. View at Google Scholar · View at Scopus
  21. M. Y. P. Kuo, J. H. Jeng, C. P. Chiang, and L. J. Hahn, “Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan,” Journal of Oral Pathology and Medicine, vol. 23, no. 2, pp. 70–74, 1994. View at Google Scholar · View at Scopus
  22. C. Caulin, T. Nguyen, M. A. Longley, Z. Zhou, X. J. Wang, and D. R. Roop, “Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity,” Cancer Research, vol. 64, no. 15, pp. 5054–5058, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Das, J. Majumder, and U. B. Dasgupta, “ras gene mutations in oral cancer in eastern India,” Oral Oncology, vol. 36, no. 1, pp. 76–80, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. J. K. Field, “The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma,” Journal of the Royal Society of Medicine, vol. 88, no. 1, pp. 35P–39P, 1995. View at Google Scholar · View at Scopus
  25. F. Nunez, O. Dominguez, E. Coto, C. Suarez-Nieto, P. Perez, and C. Lopez-Larrea, “Analysis of ras oncogene mutations in human squamous cell carcinoma of the head and neck,” Surgical Oncology, vol. 1, no. 6, pp. 405–411, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Saranath, R. G. Panchal, R. Nair et al., “Oncogene amplification in squamous cell carcinoma of the oral cavity,” Japanese Journal of Cancer Research, vol. 80, no. 5, pp. 430–437, 1989. View at Google Scholar · View at Scopus
  27. D. Saranath, S. E. Chang, L. T. Bhoite et al., “High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India,” British Journal of Cancer, vol. 63, no. 4, pp. 573–578, 1991. View at Google Scholar · View at Scopus
  28. M. Hoa, S. L. Davis, S. J. Ames, and R. A. Spanjaard, “Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma,” Cancer Research, vol. 62, no. 24, pp. 7154–7156, 2002. View at Google Scholar · View at Scopus
  29. E. Freer, N. W. Savage, G. J. Seymour, T. L. Dunn, M. F. Lavin, and R. A. Gardiner, “RAS oncogene product expression in normal and malignant oral mucosa,” Australian Dental Journal, vol. 35, no. 2, pp. 141–146, 1990. View at Google Scholar · View at Scopus
  30. M. Azuma, N. Furumoto, H. Kawamata et al., “The relation of ras oncogene product p21 expression to clinicopathological status criteria and clinical outcome in squamous cell head and neck cancer,” Cancer Journal, vol. 1, no. 9, pp. 375–380, 1987. View at Google Scholar · View at Scopus
  31. M. Y. Kuo, H. H. Chang, L. J. Hahn, J. T. Wang, and C. P. Chiang, “Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinomas in Taiwan,” Journal of Oral Pathology and Medicine, vol. 24, no. 6, pp. 255–260, 1995. View at Google Scholar · View at Scopus
  32. A. Ruol, J. K. Stephens, F. Michelassi et al., “Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma,” Journal of Surgical Oncology, vol. 44, no. 3, pp. 142–145, 1990. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Oft, R. J. Akhurst, and A. Balmain, “Metastasis is driven by sequential elevation of H-ras and Smad2 levels,” Nature Cell Biology, vol. 4, no. 7, pp. 487–494, 2002. View at Google Scholar · View at Scopus
  34. J. K. Field, M. Yiagnisis, T. D. A. Spandidos et al., “Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma,” European Journal of Surgical Oncology, vol. 18, no. 2, pp. 168–176, 1992. View at Google Scholar · View at Scopus
  35. D. Saranath, L. T. Bhoite, and M. G. Deo, “Molecular lesions in human oral cancer: the Indian scene,” European Journal of Cancer B, vol. 29, no. 2, pp. 107–112, 1993. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Hatzaki, E. Razi, K. Anagnostopoulou et al., “A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients,” Molecular and Cellular Probes, vol. 15, no. 5, pp. 243–247, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Soulières, W. Greer, A. M. Magliocco et al., “KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies,” Current Oncology, vol. 17, supplement 1, pp. S31–S40, 2010. View at Google Scholar
  38. A. Weber, L. Langhanki, F. Sommerer, A. Markwarth, C. Wittekind, and A. Tannapfel, “Mutations of the BRAF gene in squamous cell carcinoma of the head and neck,” Oncogene, vol. 22, no. 30, pp. 4757–4759, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. S. E. Chang, W. E. Marnock, P. J. Shirlaw et al., “Novel KI-ras codon 61 mutation in infiltrating leucocytes of oral squamous cell carcinoma,” The Lancet, vol. 1, no. 8645, p. 1014, 1989. View at Google Scholar · View at Scopus
  40. N. R. Lemoine, E. S. Mayall, F. S. Wyllie et al., “Activated ras oncogenes in human thyroid cancers,” Cancer Research, vol. 48, no. 16, pp. 4459–4463, 1988. View at Google Scholar · View at Scopus